Search

Your search keyword '"O'Toole, Sharon A"' showing total 254 results

Search Constraints

Start Over You searched for: Author "O'Toole, Sharon A" Remove constraint Author: "O'Toole, Sharon A"
254 results on '"O'Toole, Sharon A"'

Search Results

3. Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma

4. Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

5. Ex vivo expansion of circulating tumour cells (CTCs)

7. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer

9. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer

10. The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon

11. Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review

13. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status

16. Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study

17. Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy

18. P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer

20. Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy

21. FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer

22. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.

23. #836 Liquid biopsy isolation of circulating tumour cells from epithelial ovarian cancer patients and their prognostic significance

25. Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1

26. Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland.

27. Dynamic interplay between sortilin and syndecan-1 drives a metabolic switch during prostate cancer progression

30. Co-designing resources to support the transition from child to adult health services for young people with cerebral palsy: A design thinking approach

31. The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma

32. Influenza A virus elicits peri-vascular adipose tissue inflammation and vascular dysfunction of the aorta in pregnant mice

33. Ex Vivo Expansion of Circulating Tumour Cells (CTCs)

37. A Case with Genetic Linkage to a Child Born over Seventeen Years Prior, Successfully Treated with Surgery and Pembrolizumab

38. Harmonising the human biobanking consent process: an Irish experience

40. Noninvasive Early Biomarkers in Ovarian Cancer

41. Lncrna mort (Znf667-as1) in cancer—is there a possible role in gynecological malignancies?

42. Harmonising the human biobanking consent process: an Irish experience

47. LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?

48. An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma

49. Modern strategies to improve diagnosis and treatment of rare gynecologic tumors—current challenges and future directions

Catalog

Books, media, physical & digital resources